Project Grant W81XWH2210155
Award Date
9/1/22
Completion Date
8/31/25
Dollars Obligated
$707K
Federal Agency
Medical Command
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
New York, NY 10065, USA
Similar Awards
The Sloan-Kettering Institute For Cancer Research was awarded a $1,062,000 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 1, 2022 to August 31, 2025 to develop therapeutic activation of immunogenic cell death to improve immunotherapy for kidney cancer. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research...
The Sloan-Kettering Institute for Cancer Research was awarded a $707,997 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research to dissect ovarian cancer tumor-immune microenvironments through 3D in situ molecular profiling from September 30, 2022 to September 29, 2025. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to...
The Sloan-Kettering Institute for Cancer Research was awarded a $1,283,229 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will fund research from September 2021 through September 2025 to systematically characterize kidney cancer tumor suppressors and their role in modulating metastasis and response to immunotherapy. The Military Medical Research and Development program aims to transform military and public...
The Sloan-Kettering Institute For Cancer Research was awarded a $619,500 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The two-year award will fund research to identify and target mechanisms of lung cancer initiation. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public health care through innovative medical...
The Sloan-Kettering Institute for Cancer Research was awarded a $707,346 Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420). This 3-year grant, effective September 1, 2024, supports Sloan-Kettering's cancer research initiatives, including investigations into the tumor microenvironment, mechanisms of metastasis, epigenetic alterations in cancer, resistance to cancer therapies, aging-related biology, and hematologic malignancies....
The Department of the Army Medical Command, through the Military Medical Research and Development (CFDA 12.420) federal grant program, awarded a $924,000 Project Grant to the Sloan-Kettering Institute for Cancer Research. The 3-year grant, commencing on June 1, 2025, supports the institute's research to develop therapeutic strategies for targeting diverse KRAS mutations in lung cancer. As a leading comprehensive cancer center, Sloan-Kettering will leverage its expertise in cancer research,...
The Department of the Army Medical Command awarded a $1,347,700 Project Grant to Sloan-Kettering Institute For Cancer Research under the Military Medical Research and Development program (CFDA 12.420). The grant will support development of an implantable nanosensor for early-stage ovarian cancer detection from June 2022 through June 2025. The Military Medical Research and Development program aims to transform military and public health through innovative medical research solutions. This award...
Sloan-Kettering Institute For Cancer Research was awarded a $796,500 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) for the period of July 15, 2023 through July 14, 2026. The grant will support research to develop novel tools to improve responses to DNA-damaging therapeutics in metastatic breast cancer. As the prime recipient, Sloan-Kettering Institute For Cancer Research will leverage its expertise in cancer biology,...
The Sloan-Kettering Institute For Cancer Research was awarded an $883,531 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research into the dietary influence on liver metastasis in pancreatic cancer from September 30, 2022 to September 29, 2025. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of...
The Sloan-Kettering Institute for Cancer Research received a $177,000 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 2021 through August 2022 to elucidate alterations in three-dimensional chromatin architecture induced by SETD2 loss and their role in kidney cancer metastasis. The Military Medical Research and Development program supports basic, applied,...